Welcome back,

Decoding SSc-ILD in Hong Kong: Epidemiological Insights and Predictive Biomarkers

22 Sep 2025

Share

SYSTEMIC SCLEROSIS

FIBROTIC INTERSTITIAL LUNG DISEASES (ILD)

Login

Get access to our exclusive articles.

Author

doctor name

Dr. So, Ho

Assistant Professor, Division of Rheumatology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong

Related articles

EXPERT INSIGHT

Evaluation of cancer risks in IIM: A Hong Kong perspective on IMACS stratification
CONFERENCE UPDATE

“Plants for Joints” lifestyle intervention continues to show long-term benefits in osteoarthritis
CONFERENCE UPDATE

Attaining LLDAS and reducing GC use with anifrolumab in SLE patients: The TULIP-LTE study
CONFERENCE UPDATE

Impact of ixekizumab on structural lesions in SIJ of patients with r-axSpA: Post-hoc analysis of the COAST-V trial
CONFERENCE UPDATE

New insights on the impact of tapering GCs or immunosuppressive therapy on damage accrual after achieving LLDAS and complete remission SLE